Black Diamond Therapeutics Stock In The News

BDTX Stock  USD 1.78  0.10  5.32%   
Our overall analysis of Black Diamond's news coverage and content from conventional and social sources shows investors' bearish mood towards Black Diamond Therapeutics. The specific impact of Black Diamond news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Black Diamond's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Black Diamond headlines in addition to utilizing other, more conventional financial analysis modules. Check out Black Diamond Backtesting and Black Diamond Hype Analysis.

Black Diamond Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
https://www.globenewswire.com/news-release/2025/03/19/3045227/0/en/Servier-and-Black-Diamond-Therapeutics-Announce-Global-Licensing-Agreement-for-BDTX-4933-A-Targeted-Oncology-Therapy.html
 Bullish
Macroaxis News: globenewswire.com
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
https://www.globenewswire.com/news-release/2025/03/06/3038593/0/en/Black-Diamond-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
 Neutral
Macroaxis News: globenewswire.com
NAYA Biosciences Announces Nomination of New Board Members
https://www.globenewswire.com/news-release/2025/02/19/3028863/0/en/NAYA-Biosciences-Announces-Nomination-of-New-Board-Members.html
 Bullish
Yahoo News
NAYA Biosciences Announces Nomination of New Board Members
https://finance.yahoo.com/news/naya-biosciences-announces-nomination-board-141500586.html
 Bullish
Yahoo News
Black Diamond Therapeutics' Lead Drug Ca...
https://finance.yahoo.com/news/black-diamond-therapeutics-lead-drug-154340539.html
 Bullish
Yahoo News
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
https://finance.yahoo.com/news/gyre-therapeutics-announces-appointment-david-200500735.html
 Neutral
Yahoo News
Is Black Diamond Therapeutics (NASDAQ:BDTX) In A Good Position To Invest In Growth?
https://finance.yahoo.com/news/black-diamond-therapeutics-nasdaq-bdtx-104953222.html
 Bullish
Yahoo News
Black Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
https://finance.yahoo.com/news/black-diamond-therapeutics-announces-corporate-130000365.html
 Neutral
Yahoo News
Black Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
https://finance.yahoo.com/news/black-diamond-therapeutics-announces-topline-120000486.html
 Neutral
Yahoo News
With 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing
https://finance.yahoo.com/news/58-ownership-black-diamond-therapeutics-115806008.html
 Bullish

Black Diamond Therapeutics Past News Timeline

From Mar 21 to Dec 20Use up and down arrows to move selectionTo Mar 21Use up and down arrows to move upper selectionFrom Dec 20Use up and down arrows to move lower selectionUse TAB select grip buttons or up and down arrows to change selection100%
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Black and other traded companies coverage with news coverage. We help investors stay connected with Black headlines for the 21st of March to make an informed investment decision based on correlating the impacts of news items on Black Stock performance. Please note that trading solely based on the Black Diamond Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Black Diamond's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Black Diamond Therapeutics investors visualize upcoming and past events in order to time the market based on Black Diamond Therapeutics noise-free hype analysis.
Black Diamond stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Black earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Black Diamond that are available to investors today. That information is available publicly through Black media outlets and privately through word of mouth or via Black internal channels. However, regardless of the origin, that massive amount of Black data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Black Diamond news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Black Diamond relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Black Diamond's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Black Diamond alpha.

Black Largest EPS Surprises

Earnings surprises can significantly impact Black Diamond's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-03-10
2024-12-31-0.3117-0.280.031710 
2024-05-09
2024-03-31-0.43-0.350.0818 
2024-11-04
2024-09-30-0.37-0.27530.094725 
2021-08-12
2021-06-30-0.84-0.95-0.1113 
2024-03-12
2023-12-31-0.47-0.340.1327 
2021-05-07
2021-03-31-0.68-0.84-0.1623 
View All Earnings Estimates

Black Diamond Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Black Diamond Therap Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
news
20th of March 2025
Black Diamond Therapeutics Given Outperform Rating at Wedbush
at thelincolnianonline.com 
Google News at Macroaxis
13th of March 2025
Black Diamond Therapeutics In Decline, But Why - Seeking Alpha
at news.google.com 
Gurufocus Stories at Macroaxis
6th of March 2025
Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and...
at gurufocus.com 
Gurufocus Stories at Macroaxis
19th of February 2025
NAYA Biosciences Announces Nomination of New Board Members
at gurufocus.com 
Simply Wall St News at Macroaxis
14th of January 2025
3 US Penny Stocks With Market Caps Under 200M
at simplywall.st 
Google News at Macroaxis
30th of December 2024
Black Diamond Therapeutics Speculative Buy With Precision Oncology Catalysts - Seeking Alp...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Black Diamond in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Black Diamond's short interest history, or implied volatility extrapolated from Black Diamond options trading.

Additional Tools for Black Stock Analysis

When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…